SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 3.01 |
| Enterprise Value ($M) | -0.12 |
| Book Value ($M) | 2.72 |
| Book Value / Share | 1.94 |
| Price / Book | 1.11 |
| NCAV ($M) | 2.51 |
| NCAV / Share | 1.79 |
| Price / NCAV | 1.20 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -2.29 |
| Return on Assets (ROA) | -1.34 |
| Return on Equity (ROE) | -1.99 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.50 |
| Current Ratio | 2.50 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 4.40 |
| Assets | 4.61 |
| Liabilities | 1.89 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 5.21 |
| Operating Income | -6.73 |
| Net Income | -7.99 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -7.50 |
| Cash from Investing | 0.00 |
| Cash from Financing | 9.88 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Perceptive Advisors Llc | 3.70 | 0.00 | |
| 13G | Adage Capital Management, L.P. | 5.32 | ||
| 13G | Anson Funds Management LP | 7.10 | ||
| 13G | Ra Capital Management, L.p. | 9.90 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 24,614 | 202,447 | 12.16 | |
| 360,292 | 1,022,910 | 35.22 | |
| 14,169 | 80,346 | 17.63 | |
| 25,637 | 125,632 | 20.41 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ELTX – Elicio Therapeutics, Inc. | ELUT – Elutia Inc. |
| ENLV – Enlivex Therapeutics Ltd. | ENTO – Entero Therapeutics, Inc. |
| ENTX – Entera Bio Ltd. |
Financial data and stock pages provided by
Fintel.io